Genetron Holdings Debt 2024

Genetron Holdings Aktienanalyse

What does Genetron Holdings do?

Genetron Holdings Ltd is a Chinese company that focuses on the development of discoveries in genomic research. They are known for their advanced technologies that allow for the development of cancer diagnostics and personalized therapies. History: Genetron was founded in 2015 by Sizhen Wang, a leading expert in the field of molecular diagnostics. Since then, the company has experienced rapid growth and has become a well-known name in genomic research. In 2019, Genetron Holdings went public on the Beijing Star Board of the Chinese stock exchange. Business model and divisions: The company is divided into two main activities - diagnostics and research. In the diagnostics division, the company focuses on developing personalized medicines for cancer patients. Genetron works closely with hospitals and research institutions throughout China to develop diagnostic tools for cancer prevention. In the research department, the company is involved in the discovery of new genetic markers for various diseases. Genetron utilizes state-of-the-art technologies such as Crispr-Cas9 to edit genes and determine which genes are responsible for which diseases. Products and services: Genetron offers a range of products and services for cancer diagnostics. One of their most well-known products is the Genetron Health System, a platform for personalized medicine. The system uses genetic profiles to identify the best treatment options for patients. Genetron also offers a variety of other diagnostic tests, including tests for ovarian cancer, lung cancer, and stomach cancer. The company also offers a variety of research services. These include genetic studies, the discovery of new medical therapies, and collaboration with other companies in the field of genomic research. Conclusion: Genetron Holdings Ltd is a company with a fascinating history and a unique business model. Their dedication to innovative cancer diagnostics and personalized medicine has helped them become leaders in genomic research. The company offers a wide range of products and services and works closely with the medical community to improve the health and well-being of patients. Genetron Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Genetron Holdings's Debt Structure

Genetron Holdings's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Genetron Holdings's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Genetron Holdings’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Genetron Holdings’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Genetron Holdings stock

What is the debt of Genetron Holdings this year?

Genetron Holdings has a debt level of -17.7 CNY this year.

What was the debt of Genetron Holdings compared to the previous year?

The debt of Genetron Holdings has increased by -96.87% compared to the previous year dropped.

What are the consequences of high debt for investors in Genetron Holdings?

High debt can pose a risk for investors of Genetron Holdings, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Genetron Holdings?

Low debt means that Genetron Holdings has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Genetron Holdings affect the company?

An increase in debt of Genetron Holdings can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Genetron Holdings affect the company?

A reduction in debt of Genetron Holdings can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Genetron Holdings?

Some factors that can influence the debt of Genetron Holdings include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Genetron Holdings so important for investors?

The debts of Genetron Holdings are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Genetron Holdings take to change the debt?

To change the debt, Genetron Holdings can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Genetron Holdings pay?

Over the past 12 months, Genetron Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetron Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genetron Holdings?

The current dividend yield of Genetron Holdings is .

When does Genetron Holdings pay dividends?

Genetron Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetron Holdings?

Genetron Holdings paid dividends every year for the past 0 years.

What is the dividend of Genetron Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetron Holdings located?

Genetron Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetron Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetron Holdings from 9/12/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did Genetron Holdings pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Genetron Holdings in the year 2023?

In the year 2023, Genetron Holdings distributed 0 CNY as dividends.

In which currency does Genetron Holdings pay out the dividend?

The dividends of Genetron Holdings are distributed in CNY.